Name
GS2-01 (J): More vs less invasive axillary staging in breast cancer patients converting from node-positive to node-negative through neoadjuvant chemotherapy - AXSANA/EUBREAST 3(R) primary analysis
Date & Time
Wednesday, December 3, 2025
Speakers
Virtual Session Link
Total Minutes
04:59
OnDemand Video URL